CLINICAL TRIAL REPORT SECTIONS

Understand how a clinical trial was designed before reading its results

A trial's design decides how much its results can be trusted: whether participants were randomized, who was blinded, what the comparison arm received and how long people were followed. Ask Search+ "How was this trial designed, and how were participants allocated?" and open the cited methods text to read the details the abstract compresses into a few words.

Creating an account needs no payment.

Last updated October 2026

How to read a trial's design with Search+

  1. Upload the report, protocol and any design paper

    Some trials publish their design in a separate methods or protocol paper. Add every available document, PDF or Word, so the full design is within reach of your questions.

  2. Ask about one design feature at a time

    Ask about allocation, then blinding, then the arms, then the setting and duration. Each feature has its own passage in the methods, and separate questions keep each citation clear.

  3. Check the design against what happened

    Ask whether the report describes deviations from the planned design, such as unblinding or crossover between arms, and open those citations too.

Questions to ask about study design

Allocation

Was allocation randomized, and how was the random sequence generated and concealed?

Blinding

Who was blinded: participants, clinicians, outcome assessors or analysts?

Arms

How many arms did the trial have, and what did each one receive?

Phase and setting

What phase was the trial, and in how many sites and countries was it run?

Structure

Was it a parallel-group, crossover, factorial or cluster design?

Deviations

Were there any changes to the design after the trial started?

What to look for in a trial's design

Randomization and concealment

Randomization reduces selection bias only if the allocation was concealed from the people enrolling participants. Ask about both, not just whether the trial was called randomized.

Blinding is about who

"Double-blind" is used inconsistently. Ask exactly which groups did not know the allocation, since blinding outcome assessors matters even when participants know.

Design types answer different questions

Parallel-group, crossover, cluster and factorial designs each have their own strengths and pitfalls, and they are analyzed differently.

Phase signals purpose

Early-phase trials mostly examine safety and dosing; later-phase trials test effectiveness in larger groups. Read results in light of the phase.

Cited design details

Answers cite the methods passages they used, and Search+ does not invent page or section locations the report does not contain.

Ask across the report and protocol together

Put the related documents in one workspace and ask across all of them, or narrow to one.

Design wording and what it tells you

Wording you may seeWhat it usually signalsA follow-up question
"randomized, double-blind, placebo-controlled"A common design for testing effectivenessWho exactly was blinded, and how was blinding kept?
"open-label"Everyone knew the allocationWere outcomes assessed by someone unaware of allocation?
"crossover"Participants received both treatments in sequenceHow long was the washout period between treatments?
"cluster randomized"Groups such as clinics were randomized, not individualsHow many clusters were there?
"stratified randomization"Allocation balanced on key factorsWhich factors was randomization stratified by?
"adaptive design"Planned changes based on interim dataWhat changes were allowed, and were any made?

What is study design in a clinical trial report?

Study design in a clinical trial report is the description of how the trial was set up: how participants were allocated to groups, who was blinded, what each group received, where the trial ran, for how long and under which phase of development.

The design is the plan for producing evidence, not the evidence itself. A well-designed trial can still have problems in how it was carried out, which the results and limitations sections describe.

Study design questions

Can Search+ explain a trial's design in plain language?
Yes. Ask how the trial was designed and it answers from the methods with citations. Ask follow-ups about any term you do not know, such as allocation concealment.
Can it tell me if the trial was properly randomized?
It can show what the report says about randomization and concealment, with citations. Judging whether that was adequate is an appraisal you or an expert make from the text.
Will it find design details buried in the protocol?
If the protocol is in the same workspace, ask across the workspace and the answer can cite the protocol directly, alongside the published report.
Is this guidance on whether to join a trial or take a treatment?
No. Search+ helps you read trial documents. It does not give medical advice; discuss trials and treatments with a qualified clinician.
Can I compare designs across several trials?
Yes. Ask across the reports in one workspace how their designs differ, and the answer cites each report.
Could an answer misstate a design detail?
It could. Read the cited methods passage before relying on any design detail, because AI answers can be incomplete.

Judge the results by the design behind them

Start a workspace, upload the trial documents, and ask how the study was set up.

Start a workspace